Recently Viewed

Clear All

News & Announcements - AYM Syntex

AYM Syntex : Latest updates and developments

Announcement under Regulation 30 (LODR)-Newspaper Publication

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Statement Of Deviation Or Variation In Respect Of Preferential Issue Of Equity Shares For The Quarter Ended December 31 2025.

Board Meeting Outcome For Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended As On December 31 2025.

Board Meeting Outcome for Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended As On December 31 2025.

Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended On December 31 2025.

Announcement under Regulation 30 (LODR)-Change in Management

Top Picks

'25 funds in my portfolio. Where do I even begin?'

5 min read•By Udhayaprakash

The only way to actually lose money on your SIP

12 min read•By Pranit Mathur

How to get fixed income right for your retirement?

3 min read•By Ameya Satyawadi

The problem with your emergency fund

4 min read•By Ameya Satyawadi

Be the investor who can sleep during crises

5 min read•By Dhirendra Kumar

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Announcement under Regulation 30 (LODR)-Change in Management

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Change in Management

Announcement under Regulation 30 (LODR)-Newspaper Publication

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Statement Of Deviation Or Variation In Respect Of Preferential Issue Of Equity Shares For The Quarter Ended September 30 2025.

Explore Other Categories

See All Categories
Load more down-arrow-icon
{__(loading...)}
ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
TIPCO Engineering India 84 - 89 23-Mar-2026 to 25-Mar-2026
Central Mine Planning & Design Institute 163 - 172 20-Mar-2026 to 24-Mar-2026
Speciality Medicines 117 - 124 20-Mar-2026 to 24-Mar-2026
Emiac Technologies 93 - 98 27-Mar-2026 to 08-Apr-2026
IPO MonitorIPO Monitor